The vaccine from Pfizer-BioNTech a week or more after the second dose is 95.3% effective against coronavirus infection. Updated estimates of the effectiveness of a biological product in the fight against the COVID-19 epidemic in Israel were published by The Lancet. The authors used surveillance data from the first four months of the national […]
Tag: Pfizer-BioNTech
How Pfizer-biontech Vaccine Protects Seniors Against Life-threatening COVID-19 Cases – Report
Vaccination with anti-coronavirus vaccines from Pfizer-BioNTech and Moderna was 94% effective against hospitalization with COVID-19 in fully immunized people ≥65 years of age. This is reported in a press release by the US Centers for Disease Control and Prevention (CDC). In addition, a single dose of these mRNA vaccines resulted in 64 percent protection […]
Effectiveness of Moderna and Pfizer-BNT Against Symptoms and Hospitalization: First Estimates from the USA
American doctors have assessed the effectiveness of Moderna and Pfizer-BNT RNA vaccinations in preventing COVID-19 symptoms no longer in clinical trials, but in real conditions of mass vaccination of the US population. A preprint (not yet peer reviewed report) is available on medRxiv. The report was compiled by experts from the Mayo Clinic network using […]
This is phase IV. The first data on the Pfizer-BioNTech vaccine have appeared in Israel
In Israel, for the first time, the ability of the Pfizer-BioNTech anticoid vaccine to induce an immune response was evaluated three weeks after the first dose, that is, before the fixing (second) injection. The results for the population at high risk of catching the coronavirus – for medical professionals – are published as a preprint […]